FDA 延长了 ProSense 冷冻消融系统 De Novo 上市许可申请的审查期，预计将在 2025 年第一季度后就 ProSense 用于内分泌治疗早期低风险乳腺癌做出授权决定。 此更新来自 FDA 和 IceCure Medical 之间持续的讨论，标志着对这项创新技术的持续和彻底评估。

Mix as in mix and mingle, join and become part of a large group. To be in the mix, then, is to be included. Hence, figuratively speaking, if someone or something is in the mix for something, they’re ...